These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 1512765

  • 1. Soluble interleukin 2 receptors in polymyalgia rheumatica/giant cell arteritis. Clinical and laboratory correlations.
    Salvarani C, Macchioni P, Boiardi L, Rossi F, Casadei Maldini M, Mancini R, Beltrandi E, Spacca C, Lodi L, Portioli I.
    J Rheumatol; 1992 Jul; 19(7):1100-6. PubMed ID: 1512765
    [Abstract] [Full Text] [Related]

  • 2. Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review.
    Martinez-Taboada VM, Blanco R, Fito C, Pacheco MJ, Delgado-Rodriguez M, Rodriguez-Valverde V.
    Semin Arthritis Rheum; 2001 Feb; 30(4):257-71. PubMed ID: 11182026
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: influence of corticosteroid therapy.
    Martinez-Taboada VM, Bartolome MJ, Fernandez-Gonzalez MD, Blanco R, Rodriguez-Valverde V, Lopez-Hoyos M.
    Rheumatology (Oxford); 2003 Sep; 42(9):1055-61. PubMed ID: 12730520
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antibodies to cardiolipin and beta 2 glycoprotein I in patients with polymyalgia rheumatica and giant cell arteritis.
    Meyer O, Nicaise P, Moreau S, de Bandt M, Palazzo E, Hayem G, Chazerain P, Labarre C, Kahn MF.
    Rev Rhum Engl Ed; 1996 Apr; 63(4):241-7. PubMed ID: 8738442
    [Abstract] [Full Text] [Related]

  • 16. Clinical outcome of 149 patients with polymyalgia rheumatica and giant cell arteritis.
    Bahlas S, Ramos-Remus C, Davis P.
    J Rheumatol; 1998 Jan; 25(1):99-104. PubMed ID: 9458211
    [Abstract] [Full Text] [Related]

  • 17. A longitudinal study of anticardiolipin antibody in polymyalgia rheumatica and giant cell arteritis.
    Chakravarty K, Pountain G, Merry P, Byron M, Hazleman B, Scott DG.
    J Rheumatol; 1995 Sep; 22(9):1694-7. PubMed ID: 8523347
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Lymphocyte activation markers and von Willebrand factor antigen in Wegener's granulomatosis: potential markers for disease activity.
    D'Cruz D, Direskeneli H, Khamashta M, Hughes GR.
    J Rheumatol; 1999 Jan; 26(1):103-9. PubMed ID: 9918249
    [Abstract] [Full Text] [Related]

  • 20. Predictors for treatment success and expression of glucocorticoid receptor in giant cell arteritis and polymyalgia rheumatica.
    Braun N, Fritz P, Rieth A, Schroth W, Kimmel M, Biegger D, Zakim D, Alscher MD.
    J Rheumatol; 2009 Oct; 36(10):2269-76. PubMed ID: 19684157
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.